---
title: Buy Abiraterone 250mg Pills Online
description: Abiraterone 250mg pills treat metastatic prostate cancer in adults. Shop our secure online pharmacy for genuine medication and reliable service.
type: product
language: en 
url: https://ayudadiabetes.com/order-abiraterone-online-en
availability: in_stock
shipping:
  - type: Standard Airmail
    price: 10.00
    currency: USD
    area: Worldwide
    time: 14-21 days
  - type: Tracked Express
    price: 30.00
    currency: USD
    area: Worldwide
    tracking: true
    time: 5-9 days
price_min: 457.99
price_max: 887.99
currency: USD
offers:
  - name: 250mg x 120 pills
    price: 457.99
  - name: 250mg x 240 pills
    price: 887.99
---

# Buy Abiraterone 250mg Pills Online

Abiraterone is an oral medication used in combination with prednisone for metastatic castration-resistant prostate cancer in adult men. It inhibits androgen production to slow disease progression. Intended for patients with advanced prostate conditions. Available in 250mg pills from our online pharmacy.

## Pricing and Options

| Dosage | Pack Size | Price (USD) | Price Per Pill | Status |
| :--- | :--- | :--- | :--- | :--- |
| **250mg** | 120 pills | **$457.99** | $3.82 | In Stock |
| **250mg** | 240 pills | **$887.99** | $3.70 | In Stock |


[Buy Now](https://ayudadiabetes.com/order-abiraterone-online-en)

## Introduction 

Abiraterone is a synthetic oral medication used to treat advanced prostate cancer. The active compound is Abiraterone and it is supplied as a 250 mg tablet taken by mouth. It belongs to the class of CYP-17 inhibitors, which block the production of androgens that fuel tumour growth. In the United Kingdom, the drug is approved for men with metastatic castration-resistant prostate cancer (mCRPC) and for those with high-risk metastatic castration-sensitive disease when used together with androgen-deprivation therapy. 

---

## Quick Reference Facts 

**Active Ingredient** 
: Abiraterone 

**Form** 
: pill 250 mg 

**Primary and Off-Label Uses** 
: Metastatic castration-resistant prostate cancer 
: Metastatic castration-sensitive prostate cancer 

---

## What is Abiraterone? 

Abiraterone is the generic version of medications containing the active compound Abiraterone. It is marketed under the brand name Zytiga in many countries, but the generic formulation is bioequivalent and offers the same therapeutic effect at a lower cost. The drug is manufactured by several licensed pharmaceutical companies that hold marketing authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA). As a CYP-17 inhibitor, it is taken daily as a single 250 mg tablet, usually in combination with low-dose prednisone to mitigate mineralocorticoid-related side effects. 

---

## How Abiraterone Works 

Abiraterone selectively blocks the enzyme CYP17A1 (17α-hydroxylase/17,20-lyase) which is essential for androgen synthesis in the testes, adrenal glands and within the tumour itself. By inhibiting this pathway, circulating testosterone and dihydrotestosterone levels fall dramatically, depriving prostate cancer cells of the hormonal stimulus required for proliferation. 

The drug is absorbed quickly after oral administration, reaching peak plasma concentrations in about 2 hours when taken on an empty stomach. Food reduces its bioavailability by up to 40 percent, which is why patients are advised to fast before and after dosing. Abiraterone is metabolised primarily by the liver (CYP3A4) to inactive metabolites and eliminated chiefly via the feces. Its half-life is approximately 12 hours, supporting once-daily dosing. Co-administration of prednisone (5 mg twice daily) provides glucocorticoid replacement, preventing excessive mineralocorticoid activity that can cause hypertension, hypokalaemia and fluid retention. 

---

## Conditions Treated with Abiraterone 

- **Metastatic castration-resistant prostate cancer (mCRPC)** - In men whose disease has progressed despite traditional androgen-deprivation therapy, Abiraterone further reduces androgen production, slowing tumour growth and extending overall survival, as demonstrated in the COU-AA-301 trial. 

- **Metastatic castration-sensitive prostate cancer (mCSPC)** - When combined with standard androgen-deprivation therapy, Abiraterone improves radiographic progression-free survival and overall survival in high-risk men, as shown in the LATITUDE study. 

Both indications rely on the drug’s ability to suppress androgen synthesis beyond what orchiectomy or luteinising-hormone-releasing hormone (LHRH) agonists achieve alone. 

---

## Is Abiraterone the Right Medication for You? 

Abiraterone is most appropriate for adult men with advanced prostate cancer who have either castration-resistant disease or high-risk castration-sensitive disease and who are already receiving or will receive continuous androgen-deprivation therapy. The medication is particularly valuable when the cancer has spread to bone or visceral organs, where hormonal control is essential. 

Contra-indications include severe hepatic impairment (Child-Pugh C), known hypersensitivity to Abiraterone or any tablet excipients, and situations where glucocorticoid co-administration is unsafe (e.g., uncontrolled infections). Caution is advised in patients with cardiovascular disease, uncontrolled hypertension, or a history of electrolyte disturbances, as the drug can exacerbate these conditions. 

In summary, patients who are fit for long-term oral therapy, can tolerate low-dose prednisone, and require additional androgen suppression beyond conventional methods are the best candidates for Abiraterone. 

---

## Buying Abiraterone from [our online pharmacy](https://ayudadiabetes.com/order-abiraterone-online-en) 

### Why Choose Our Service? 
Accessing specialised oncology medicines can be challenging through conventional channels, especially when cost or supply constraints arise. Our platform provides a reliable route to obtain Abiraterone at a price close to the manufacturer’s wholesale cost, helping to alleviate financial pressure. 

### Quality & Safety Assurance 
We partner with licensed international pharmacies to ensure quality and authenticity. Every batch of Abiraterone is sourced from MHRA-approved manufacturers and undergoes rigorous verification before it leaves the warehouse. 

### Pricing & Access 
Because we dispense the generic formulation, the price is markedly lower than the branded version, often saving patients up to 40 percent. This makes long-term therapy more sustainable for those facing chronic treatment. 

### Discreet Delivery 
Orders are packed in unbranded, secure packaging and shipped via express couriers that typically deliver within 7 days to the UK. Standard airmail arrives in approximately 3 weeks. Your privacy is protected at every step. 

---

## Use: Dosing, Missed Dose, Overdose 

- **Standard dosing** - One 250 mg tablet taken orally once daily on an empty stomach (at least 1 hour before or 2 hours after food). 
- **With prednisone** - 5 mg taken twice daily to counteract mineralocorticoid excess. 

- **Missed dose** - If you realise a dose was missed within 12 hours, take it immediately unless it is almost time for the next scheduled dose; do not double-dose. 

- **Overdose** - Suspected overdose should be treated as a medical emergency. Seek immediate assistance, as excessive inhibition of CYP17 can lead to severe hypertension, hypokalaemia, and hepatic toxicity. 

- **Practical precautions** - Avoid grapefruit juice, which can increase plasma concentrations. Do not operate machinery if you feel dizzy or fatigued. Alcohol should be limited, as it may worsen liver enzyme elevations. 

---

## Safety Information 

### ⚠️ Who Should Not Take Abiraterone 

- Severe hepatic impairment (Child-Pugh class C) 
- Known hypersensitivity to Abiraterone or any tablet ingredients 
- Patients who cannot receive concomitant glucocorticoids (e.g., active uncontrolled infections) 

### Common Side Effects 

- Fatigue, mild nausea, and headache (occurring in ≤ 30 % of patients) - usually manageable with rest and supportive care. 
- Hypertension and fluid retention - monitor blood pressure regularly; diuretics may be prescribed if needed. 
- Low blood potassium (hypokalaemia) - dietary potassium intake and routine electrolyte checks are advised. 

### Serious Side Effects (Seek Immediate Medical Help) 

- Severe liver enzyme elevation (ALT/AST > 5 × ULN) - may indicate drug-induced hepatitis. 
- Acute adrenal insufficiency - rare but possible if prednisone is abruptly stopped. 
- Grade 3-4 hypertension or cardiac failure - requires urgent evaluation. 

### Drug & Food Interactions 

- **CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin)** - increase Abiraterone exposure; dose adjustment or avoidance recommended. 
- **CYP2D6 inhibitors (e.g., fluoxetine, paroxetine)** - may elevate steroid precursors, enhancing mineralocorticoid side effects. 
- **Antihypertensives** - ACE inhibitors or ARBs may be required to control Abiraterone-induced blood pressure rise. 
- **Mineralocorticoid-sparing agents** - concurrent use of eplerenone or spironolactone can mitigate fluid retention. 

---

## Off-Label and Investigational Uses of Abiraterone 

Clinical investigations have explored Abiraterone in hormone-dependent breast cancer, given its ability to suppress estrogen synthesis via CYP17 inhibition. Small-scale studies suggest modest activity, but larger trials are required before any recommendation. Occasionally, oncologists have employed Abiraterone in rare cases of adrenal carcinoma that produce excess androgens, leveraging its downstream blockade of steroidogenesis. These applications remain experimental and are not approved by regulatory bodies. 

---

## Storage & Handling 

- **Temperature:** Store tablets at 15-30 °C (59-86 °F). 
- **Moisture:** Keep container tightly closed; avoid excess humidity. 
- **Light:** Protect from direct sunlight. 
- **Expiry:** Do not use after the printed expiry date; discard any tablets that appear discoloured or damaged. 
- **Disposal:** Return unused medication to a pharmacy take-back scheme or follow local hazardous waste guidelines. 

---

## Frequently Asked Questions 

**Practical Use & Lifestyle** 

- **Can I travel internationally with Abiraterone?** 
 Yes, but keep the medication in its original labelled container, carry a copy of the prescription, and declare it at customs if required by the destination country. 

- **Should I take Abiraterone with meals?** 
 The tablet must be taken on an empty stomach; food reduces its absorption and may lessen its effectiveness. 

- **Is it safe to drink alcohol while on Abiraterone?** 
 Moderate consumption is generally permissible, but excessive alcohol can worsen liver enzyme elevations, so limit intake and monitor liver function. 

- **Will Abiraterone affect my ability to exercise?** 
 Most patients tolerate normal activity, but fatigue or hypertension may require temporary modification of intense workouts. 

**Product & Formulation Details** 

- **What does an Abiraterone tablet look like?** 
 The generic 250 mg tablet is typically white, round, and film-coated, but appearance may vary slightly between manufacturers. 

- **Can the tablet be split or crushed?** 
 Splitting is not recommended because it may result in uneven dosing; crushing could affect absorption and is discouraged. 

- **Are any inactive ingredients known to cause allergies?** 
 Common excipients include lactose and magnesium stearate; patients with specific intolerances should discuss alternatives with their pharmacist. 

**Regulatory & Safety Nuances** 

- **Do UK drug testing programmes screen for Abiraterone?** 
 Abiraterone is not a substance screened in standard occupational or sports drug tests, as it is not considered a performance-enhancing drug. 

- **Is Abiraterone covered by the NHS?** 
 In England, Abiraterone may be prescribed on the Cancer Drugs Fund for eligible patients meeting specific clinical criteria. 

- **Can I purchase Abiraterone without a prescription in the UK?** 
 No, it is a prescription-only medicine; a qualified prescriber must authorise its use. 

**Scientific & Clinical Curiosity** 

- **What were the key trials that led to approval?** 
 The COU-AA-301 (mCRPC) and LATITUDE (mCSPC) phase III trials demonstrated significant overall-survival benefits, forming the basis for regulatory approval. 

- **How does Abiraterone differ from older anti-androgens?** 
 Older agents block androgen receptors, whereas Abiraterone reduces androgen production at the source, providing a complementary mechanism. 

- **Is there a patent still on Abiraterone?** 
 The original patents have expired, allowing multiple generic manufacturers to produce the 250 mg tablet. 

---

## Glossary 

**CYP17A1** 
: An enzyme (17α-hydroxylase/17,20-lyase) that catalyses key steps in androgen and cortisol synthesis; the primary target of Abiraterone. 

**Metastatic castration-resistant prostate cancer (mCRPC)** 
: Prostate cancer that has spread beyond the prostate and continues to progress despite low testosterone levels from hormonal therapy. 

**Mineralocorticoid excess** 
: A physiological state characterised by fluid retention, hypertension, and low potassium, often arising from inhibition of cortisol synthesis without glucocorticoid replacement. 

**Bioequivalence** 
: The property whereby a generic drug delivers the same amount of active ingredient into the bloodstream as the reference (brand) product. 

---

## Disclaimer 

The information provided about **Abiraterone** is for general knowledge only. It does not replace professional medical consultation. All treatment decisions, including those regarding off-label use, should be made under the supervision of a qualified healthcare provider. We assume all readers are responsible adults capable of making informed decisions about their health. [our online pharmacy](https://ayudadiabetes.com/order-abiraterone-online-en) offers access to **Abiraterone** for individuals who may have limited availability through traditional pharmacies, prescription-based insurance schemes, or who are seeking affordable generic alternatives. Always consult your doctor before starting, changing, or discontinuing any medication.